A thermosensitive gel pharmaceutical preparation and preparation method thereof

A temperature-sensitive gel and pharmaceutical preparation technology, which is applied in the directions of drug combination, pharmaceutical formulation, aerosol delivery, etc., can solve the problem of not achieving the sustained release effect of the preparation, achieve good reference value and application significance, and improve medication compliance. Effect

CN103622902BActive Publication Date: 2016-12-21SHANGHAI MODERN PHARMA ENG INVESTIGATION CENT
3 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2016-12-21

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a temperature-sensitive gel pharmaceutical preparation and a preparation method thereof. The raw material formula of the temperature-sensitive gel pharmaceutical preparation contains a drug, a temperature-sensitive gel composition, and an excipient C; the excipient C is one or more of metal salts, carbohydrates, and hydrophilic polymers for injection; The metal salt is a pharmaceutically acceptable metal salt that dissociates divalent metal cations in an aqueous solution; the drug is a substance A that exists in an anion form in an aqueous solution, and the substance A is a protein drug, a polypeptide One or more of class drugs and glycopeptide antibiotics. The preparation method comprises the following steps: according to the formula of raw materials, the drug is dissolved in the temperature-sensitive gel composition in the form of solution. The temperature-sensitive gel pharmaceutical preparation is especially suitable for water-soluble drugs, reduces the burst release effect, releases the drugs slowly, and achieves the purpose of sustained release.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a temperature-sensitive gel pharmaceutical preparation and a preparation method thereof. Background technique

[0002] Exenatide (also known as exenatide or exendin-4) was first isolated from the saliva secretion of giant monster lizard (Heloderm suspectum), and it is a polypeptide containing 39 amino acids (Eng, J. et al., J.Biol.Chem ., 1990 (265): 20259-20262; or J.Biol.Chem., 1992 (267): 7402-7405), its amino acid sequence is similar to glucagon-like peptide-1 (GLP-1) There are about 53% identical components. Pharmacological studies have found that exenatide has a similar effect to GLP-1, that is, it can stimulate pancreatic β cells to secrete insulin. Exenatide can act on GLP-1 receptors on certain insulin-secreting cells in vitro, on interspersed acinar cells from the pancreas of guinea pigs, or on parietal cells from the stomach; it has also been reported that Exenatide The peptide stimulates somatostatin release and ...

Examples

Embodiment 1-2

[0083] Polymer A: hydrophilic PLGA-PEG-PLGA copolymer (polymer A, 1571-1500-1571, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.15) ; Polymer B: appropriate amount of hydrophobic PLGA-PEG-PLAG copolymer (polymer B, 1255-1500-1255, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.23 ).

[0084] Wherein, the synthesis process of polymers A and B refers to the synthesis methods in Examples 1 and 3 of the Chinese patent application with application number 200910049664.6.

[0085] Get polymer A and polymer B, add deionized water, dissolve under magnetic stirring, configure polymer, the weight ratio of polymer A / polymer B is 1 / 1, and the total polymer concentration is 25% (w / The aqueous solution of w) was passed through a 0.22 μm filter membrane for later use, and was...

Embodiment 3-4

[0090] Polymer A: hydrophilic PLGA-PEG-PLGA copolymer (polymer A, 1571-1500-1571, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.15) ; Polymer B: appropriate amount of hydrophobic PLGA-PEG-PLAG copolymer (polymer B, 1255-1500-1255, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.23 ).

[0091] Wherein, the synthesis process of polymers A and B refers to the synthesis methods in Examples 1 and 3 of the Chinese patent application with application number 200910049664.6.

[0092] Get polymer A and polymer B, add deionized water, dissolve under magnetic stirring, configure polymer, the weight ratio of polymer A / polymer B is respectively 1 / 1, and total polymer concentration is 25% (w / The aqueous solution of w) was passed through a 0.22 μm filter membrane for later use...

Embodiment 5-6

[0097] Polymer A: hydrophilic PLGA-PEG-PLGA copolymer (polymer A, 1571-1500-1571, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.15) ; Polymer B: appropriate amount of hydrophobic PLGA-PEG-PLAG copolymer (polymer B, 1255-1500-1255, the molecular weight of the block is the number average molecular weight, the block molar ratio LA / GA=4, the molecular weight distribution coefficient is 1.23 ).

[0098] Wherein, the synthesis process of polymers A and B refers to the synthesis methods in Examples 1 and 3 of the Chinese patent application with application number 200910049664.6.

[0099] Get polymer A and polymer B, add deionized water, dissolve under magnetic stirring, configure polymer, the weight ratio of polymer A / polymer B is respectively 1 / 1, and total polymer concentration is 25% (w / The aqueous solution of w) was passed through a 0.22 μm filter membrane for later use...